Photronics, Inc. (PLAB) - Q3 FY2024 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended July 28, 2024 (Q3 FY2024). Photronics, Inc. is a leading manufacturer of photomasks used in the fabrication of integrated circuits (ICs) and flat-panel displays (FPDs). The company operates 11 manufacturing facilities globally, including a significant joint venture in China (PDMCX) with Dai Nippon Printing Co., Ltd. (DNP).
Key Financial Metrics
| Metric | Q3 FY2024 | Q3 FY2023 | YTD FY2024 | YTD FY2023 |
|---|---|---|---|---|
| Revenue | $211.0 million | $224.2 million | $644.3 million | $664.6 million |
| Gross Profit | $75.1 million | $86.8 million | $233.6 million | $251.3 million |
| Gross Margin | 35.6% | 38.7% | 36.3% | 37.8% |
| Operating Income | $52.1 million | $65.3 million | $165.7 million | $188.3 million |
| Net Income (Total) | $48.2 million | $48.3 million | $143.6 million | $136.5 million |
| Net Income (Attributable to Shareholders) | $34.4 million | $27.0 million | $96.8 million | $80.9 million |
| Diluted EPS | $0.55 | $0.44 | $1.55 | $1.31 |
| Cash & Equivalents | $537.3 million | $448.5 million | Balance Sheet | |
| Short-term Investments | $69.0 million | $12.9 million | Balance Sheet | |
| Total Debt | $20.1 million | $24.6 million | Balance Sheet | |
| Operating Cash Flow (YTD) | $193.1 million | $195.6 million | Nine Months |
Material Changes vs. Prior Period
- Revenue Decline: Q3 revenue decreased 5.9% year-over-year (YoY) and 2.8% sequentially. The decline was driven by soft demand in mainstream IC and FPD segments, partially offset by growth in high-end IC photomasks (+9.2% YoY).
- Margin Compression: Gross margin decreased 310 basis points YoY to 35.6%, primarily due to lower revenue impacting operating leverage and increased equipment/overhead costs as a percentage of revenue.
- Profitability Growth: Despite revenue declines, Net Income attributable to shareholders increased 27.5% YoY ($34.4M vs $27.0M). This was driven by a significant favorable foreign currency transaction gain of $4.1M in Q3 (compared to a $4.5M loss in Q3 FY23) and higher interest income ($6.1M vs $3.8M).
- Noncontrolling Interests: Net income attributable to noncontrolling interests (primarily the PDMCX joint venture) decreased to $13.8M from $21.3M in the prior year quarter.
- Capital Expenditures: YTD investing cash outflows increased significantly to $142.1M (from $64.2M YoY), driven by $87.7M in property, plant, and equipment purchases and increased short-term investment activity.
Guidance, Outlook, and Risks
- Guidance: The filing states that specific business outlook and guidance were provided in the Q3 earnings release and conference call, which are not incorporated into this text. Management estimates full-year FY24 capital expenditures will be approximately $130 million.
- Share Repurchase: On August 28, 2024, the Board authorized an increase to the share repurchase program, raising the remaining authorization from $31.7 million to $100 million. No shares were repurchased in Q3.
- Market Risks: The company faces significant foreign currency exposure, particularly to the New Taiwan Dollar, South Korean Won, and RMB. A 10% adverse movement in these currencies could result in a pre-tax loss of $57.7 million.
- Operational Risks: Demand is tied to semiconductor design activity rather than end-product sales volumes. Backlogs have normalized to less than a month for most high-demand products after expanding to 2-3 months in prior periods.
Investor Verification Checklist
- Revenue Mix: Verify the sustainability of the high-end IC revenue growth (+9.2% YoY) versus the continued decline in mainstream segments.
- FX Impact: Assess the volatility of earnings due to foreign currency transaction gains/losses, which swung from a $4.5M loss to a $4.1M gain between Q3 FY23 and Q3 FY24.
- Joint Venture Performance: Monitor the profitability of the PDMCX joint venture, as noncontrolling interest income dropped significantly ($21.3M to $13.8M).
- Capital Allocation: Confirm the execution of the $130M full-year CapEx plan and the utilization of the newly expanded $100M share repurchase authorization.
- Margin Pressure: Evaluate management's ability to offset rising equipment and overhead costs as a percentage of revenue to stabilize gross margins.